Thurfjell, L., Lötjönen, J., Lundqvist, R., Koikkalainen, J., Soininen, H., Waldemar, G.
, Brooks, D. J. & Vandenberghe, R. (2012).
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment.
Neurodegenerative Diseases,
10(1-4), 246-9.
https://doi.org/10.1159/000335381
Weintraub, D., Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L. M., Eberling, J., Espay, A. J., Foster, E. D., Leverenz, J. B., Litvan, I., Richard, I., Troyer, M. D., Hawkins, K. A., Marek, K. ... Hogarth, P. (2015).
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
Movement Disorders,
30(7), 919-927.
https://doi.org/10.1002/mds.26170
Sabers, A.
, Møller, A., Dam, M., Smed, A., Arlien-Søborg, P., Buchman, J., Andersen, E. B., Boesen, F., Dam, A. M., Lyon, B. B. & Pedersen, B. (1995).
Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy.
Acta Neurologica Scandinavica,
92, 19-27.
Kjærgaard, K., Mikkelsen, A. C. D., Landau, A., Eriksen, P. L., Jalan, R.
, Hamilton-Dutoit, S. J., Magnusson, N. E., Mookerjee, R. P.
, Bay-Richter, C. & Thomsen, K. L. (2020).
Cognitive dysfunction occurs early in experimentally induced NAFLD and is associated with systemic inflammation. Poster session presented at ILC 2020; The digital international liver congress .
Mikkelsen, A. C. D., Kjærgaard, K., Bay-Richter, C., Landau, A., Eriksen, P. L., Jalan, R.
, Hamilton-Dutoit, S. J., Chen, F., Vilstrup, H. V. A., Magnusson, N. E., Mookerjee, R. P.
& Thomsen, K. L. (2021).
Cognitive dysfunction is associated with systemic inflammation and neuroinflammation in a rodent model of non-alcoholic steatohepatitis. Poster session presented at Digital NAFLD Summit 2021.
Kjærgaard, K., Mikkelsen, A. C. D., Landau, A., Eriksen, P. L., Hamilton-Dutoit, S. J., Magnusson, N. E.
, Thomsen, M., Chen, F., Vilstrup, H. V. A., Mookerjee, R. P.
, Bay-Richter, C. & Thomsen, K. L. (2024).
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.
JHEP Reports,
6(3), Article 100992.
https://doi.org/10.1016/j.jhepr.2023.100992
Abrahams, S., Goldstein, L. H., Lloyd, C. M.
, Brooks, D. J. & Leigh, P. N. (1995).
Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation.
Journal of the Neurological Sciences,
129(SUPPL.), 54-55.
https://doi.org/10.1016/0022-510X(95)00063-8
Sawamoto, N., Piccini, P., Hotton, G.
, Pavese, N., Thielemans, K.
& Brooks, D. J. (2008).
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
Brain,
131(5), 1294-1302.
https://doi.org/10.1093/brain/awn054
Khan, J., Quamhawi, Z., Tai, Y. F., Bain, P. G., Nandi, D., Gunning, S.
& Pavese, N. (2016).
Cognitive change following deep brain stimulation in patients with movement disorders.
Movement Disorders,
31, S38-S38.
Josefsen, L. G.
, Møller, A. & Linnet, J. (2008).
Cognitive bias in poker. Poster session presented at 8th annual NCRG conference on pathological gambling, Las Vegas, United States.
Pavese, N., Napolitano, A., De Laco, G., Canapicchi, R., Collavoli, P. L., Lucetti, C., Gambaccini, G. & Bonuccelli, U. (1999).
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study.
Italian Journal of Neurological Sciences,
20(3), 171-178.
https://doi.org/10.1007/s100720050028
Pasquini, J., Durcan, R., Wiblin, L.
, Gersel Stokholm, M., Rochester, L.
, Brooks, D. J., Burn, D.
& Pavese, N. (2019).
Clinical implications of early caudate dysfunction in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry,
90(10), 1098-1104.
https://doi.org/10.1136/jnnp-2018-320157
Bellini, G., Best, L. A., Brechany, U., Mills, R.
& Pavese, N. (2020).
Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease.
Movement Disorders Clinical Practice,
7(4), 373-382.
https://doi.org/10.1002/mdc3.12938
Qamhawi, Z., Towey, D., Shah, B., Pagano, G., Seibyl, J., Marek, K.
, Borghammer, P., Brooks, D. J. & Pavese, N. (2015).
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
Brain,
138, 2964-2973.
https://doi.org/10.1093/brain/awv215
Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G.
, Brooks, D. J., Lees, A. J. & Piccini, P. (2006).
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study.
Neurology,
67(9), 1612-1617.
https://doi.org/10.1212/01.wnl.0000242888.30755.5d
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A.
, Brooks, D. J. & Piccini, P. (2002).
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study.
Annals of Neurology,
52(6), 849-853.
https://doi.org/10.1002/ana.10417
Lang, A., Siderowf, A., Macklin, E., Poewe, W.
, Brooks, D., Fernandez, H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C., Postuma, R., Simon, D., Tolosa, E., Mollenhauer, B., Byrne, M., Fraser, K., Xiao, J., Sapir, I., Inra, J. ... Fox, T. (2021).
Cinpanemab in Early Parkinson's Disease: Phase 2 SPARK Study Results.
Movement Disorders,
36(S1), S180-S181. Article 408.
https://doi.org/10.1002/mds.28794
Politis, M., Wilson, H., Wu, K.
, Brooks, D. J. & Piccini, P. (2017).
Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients.
NeuroImage: Clinical,
16, 455-460.
https://doi.org/10.1016/j.nicl.2017.08.013
Isaacs, J. D., Rakshi, J., Baker, R.
, Brooks, D. J. & Warrens, A. N. (2005).
Chorea associated with thyroxine replacement therapy.
Movement Disorders,
20(12), 1656-1657.
https://doi.org/10.1002/mds.20603
Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M.
, Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D.
, Fedorova, T. D., Santamaria, J.
, Møller, A., Gaig, C., Hiraoka, K.
, Brooks, D. J., Okamura, N.
, Borghammer, P., Tolosa, E.
& Pavese, N. (2020).
Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder.
European Journal of Neurology,
27(4), 644-652.
https://doi.org/10.1111/ene.14127
Yarnall, A. J., Breen, D. P., Duncan, G. W., Khoo, T. K., Coleman, S. Y., Firbank, M. J., Nombela, C., Winder-Rhodes, S., Evans, J. R., Rowe, J. B., Mollenhauer, B., Kruse, N., Hudson, G., Chinnery, P. F., O'Brien, J. T., Robbins, T. W., Wesnes, K.
, Brooks, D. J., Barker, R. A. ... ICICLE-PD Study Group (2014).
Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study.
Neurology,
82(4), 308-16.
https://doi.org/10.1212/WNL.0000000000000066
Tai, Y. F., Ahsan, R. L., De Yébenes, J. G.
, Pavese, N., Brooks, D. J. & Piccini, P. (2007).
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: An 18F-dopa PET study.
Journal of Neural Transmission,
114(3), 337-340.
https://doi.org/10.1007/s00702-006-0536-0
Mansur, A., Rabiner, E. A., Comley, R. A., Lewis, Y., Middleton, L. T., Huiban, M., Passchier, J., Tsukada, H., Gunn, R. N. & MIND-MAPS Consortium (2020).
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J
C-SA-4503, and 11C-UCB-JC-SA-4503, and 11C-UCB-J1.
Journal of Nuclear Medicine,
61(1), 96-103.
https://doi.org/10.2967/jnumed.119.228080
Myers, J. F. M., Rosso, L., Watson, B. J., Wilson, S. J., Kalk, N. J., Clementi, N.
, Brooks, D. J., Nutt, D. J., Turkheimer, F. E. & Lingford-Hughes, A. R. (2012).
Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images.
Journal of Cerebral Blood Flow and Metabolism,
32(4), 731-44.
https://doi.org/10.1038/jcbfm.2011.177
Krogsbaek, M., Larsen, N. Y., Landau, A. M., Sanchez, C. & Nyengaard, J. R. (2023).
Changes in hypothalamic mu-opioid receptor expression following acute olanzapine treatment in female rats: implications for feeding behavior.
Journal of Chemical Neuroanatomy,
132, Article 102324.
https://doi.org/10.1016/j.jchemneu.2023.102324
Weeks, R. A., Scott, J.
, Brooks, D. J., Hodgson, H., Cohen, J. & Lynn, W. A. (1996).
Cerebral Whipple's disease.
British Medical Journal,
312(7027), 371-373.
Grover, V. P. B.
, Pavese, N., Koh, S.-B., Wylezinska, M., Saxby, B. K., Gerhard, A., Forton, D. M.
, Brooks, D. J., Thomas, H. C. & Taylor-Robinson, S. D. (2012).
Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation.
Journal of Viral Hepatitis,
19(2), e89-96.
https://doi.org/10.1111/j.1365-2893.2011.01510.x
Nagahama, Y., Fukuyama, H., Turjanski, N., Kennedy, A., Yamauchi, H., Ouchi, Y., Kimura, J.
, Brooks, D. J. & Shibasaki, H. (1997).
Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls.
Movement Disorders,
12(5), 691-696.
https://doi.org/10.1002/mds.870120510
Firbank, M. J., Yarnall, A. J., Lawson, R. A., Duncan, G. W., Khoo, T. K., Petrides, G. S., O'Brien, J. T., Barker, R. A., Maxwell, R. J.
, Brooks, D. J. & Burn, D. J. (2017).
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
Journal of Neurology, Neurosurgery & Psychiatry,
88(4), 310-316.
https://doi.org/10.1136/jnnp-2016-313918
Leenders, K. L., Perani, D., Lammertsma, A. A., Heather, J. D., Buckingham, P., Jones, T., Healy, M. J. R., Gibbs, J. M., Wise, R. J. S., Hatazawa, J., Herold, S., Beaney, R. P.
, Brooks, D. J., Spinks, T., Rhodes, C. & Frackowiak, R. S. J. (1990).
Cerebral blood flow, blood volume and oxygen utilization: Normal values and effect of age.
Brain,
113(1), 27-47.
https://doi.org/10.1093/brain/113.1.27
Koepp, M. J., Richardson, M. P.
, Brooks, D. J., Poline, J. B., Van Paesschen, W., Friston, K. J. & Duncan, J. S. (1996).
Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis.
Brain,
119(5), 1677-1687.
https://doi.org/10.1093/brain/119.5.1677
Richardson, M. P., Koepp, M. J.
, Brooks, D. J., Coull, J. T., Grasby, P., Fish, D. R. & Duncan, J. S. (1998).
Cerebral activation in malformations of cortical development.
Brain,
121(7), 1295-1304.
https://doi.org/10.1093/brain/121.7.1295
Koepp, M. J., Richardson, M. P.
, Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (1997).
Central benzodiazepine/γ-aminobutyric acid(A) receptors in idiopathic generalized epilepsy: An [11C]flumazenil positron emission tomography study.
Epilepsia,
38(10), 1089-1097.
https://doi.org/10.1111/j.1528-1157.1997.tb01198.x
Hammers, A., Koepp, M. J., Richardson, M. P., Labbé, C.
, Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (2001).
Central benzodiazepine receptors in malformations of cortical development: A quantitative study.
Brain,
124(8), 1555-1565.
Mínguez-Castellanos, A., Escamilla-Sevilla, F., Hotton, G. R., Toledo-Aral, J. J., Ortega-Moreno, Á., Méndez-Ferrer, S., Martín-Linares, J. M., Katati, M. J., Mir, P., Villadiego, J., Meersmans, M., Pérez-García, M.
, Brooks, D. J., Arjona, V. & López-Barneo, J. (2007).
Carotid body autotransplantation in Parkinson disease: A clinical and positron emission tomography study.
Journal of Neurology, Neurosurgery & Psychiatry,
78(8), 825-831.
https://doi.org/10.1136/jnnp.2006.106021
Pavese, N., Rimoldi, O., Gerhard, A.
, Brooks, D. J. & Piccini, P. (2004).
Cardiovascular effects of methamphetamine in Parkinson's disease patients.
Movement Disorders,
19(3), 298-303.
https://doi.org/10.1002/mds.10651
Knight, W. D., Okello, A. A., Ryan, N. S., Turkheimer, F. E., Rodríguez Martinez De Llano, S., Edison, P., Douglas, J., Fox, N. C.
, Brooks, D. J. & Rossor, M. N. (2011).
Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
Brain,
134(1), 293-300.
https://doi.org/10.1093/brain/awq310
Madsen, L. S., Nielsen, R. B.
, Parbo, P., Ismail, R., Mikkelsen, I. K., Gottrup, H.
, Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2022).
Capillary function progressively deteriorates in prodromal Alzheimer’s disease: A longitudinal MRI perfusion study.
Aging Brain,
2, Article 100035.
https://doi.org/10.1016/j.nbas.2022.100035
Nielsen, R. B., Egefjord, L.
, Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H.
, Rungby, J., Eskildsen, S. F. & Østergaard, L. (2017).
Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
Alzheimer's & Dementia,
13(10), 1143-1153.
https://doi.org/10.1016/j.jalz.2017.02.007
Madsen, L. S., Kjeldsen, P. L., Ismail, R.
, Parbo, P., Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2024).
Capillary dysfunction in healthy elderly APOE ε4 carriers with raised brain Aβ deposition.
Alzheimer's & Dementia,
20(1), 459-471.
https://doi.org/10.1002/alz.13461
Madsen, L. S., Parbo, P., Ismail, R., Gottrup, H.
, Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2023).
Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease.
Neurobiology of Aging,
123, 1-9.
https://doi.org/10.1016/j.neurobiolaging.2022.12.006
Edison, P., Hinz, R., Ramlackhansingh, A., Thomas, J., Gelosa, G., Archer, H. A., Turkheimer, F. E.
& Brooks, D. J. (2012).
Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans? NeuroImage,
60(3), 1716-23.
https://doi.org/10.1016/j.neuroimage.2012.01.099
Grecchi, E., Doyle, O. M., Bertoldo, A.
, Pavese, N. & Turkheimer, F. E. (2014).
Brain shaving: Adaptive detection for brain PET data.
Physics in Medicine and Biology,
59(10), 2517-2534.
https://doi.org/10.1088/0031-9155/59/10/2517
Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., Landau, A. M., Jakobsen, S. & Jakobsen, S. (2015).
Brain Serotonin Transporter Binding In a Minipig Model of Parkinson's Disease. Poster session presented at Brain & Brain PET 2015, Vancouver, Canada.
Williams, T. M., Daglish, M. R. C., Lingford-Hughes, A., Taylor, L. G., Hammers, A.
, Brooks, D. J., Grasby, P., Myles, J. S. & Nutt, D. J. (2007).
Brain opioid receptor binding in early abstinence from opioid dependence: Positron emission tomography study.
British Journal of Psychiatry,
191(JULY), 63-69.
https://doi.org/10.1192/bjp.bp.106.031120
Williams, T. M., Davies, S. J. C., Taylor, L. G., Daglish, M. R. C., Hammers, A.
, Brooks, D. J., Nutt, D. J. & Lingford-Hughes, A. (2009).
Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study.
European Neuropsychopharmacology,
19(10), 740-748.
https://doi.org/10.1016/j.euroneuro.2009.06.007
Lewis, S. J.
, Pavese, N., Rivero-Bosch, M., Eggert, K., Oertel, W., Mathias, C. J.
, Brooks, D. J. & Gerhard, A. (2012).
Brain monoamine systems in multiple system atrophy: a positron emission tomography study.
Neurobiology of Disease,
46(1), 130-6.
https://doi.org/10.1016/j.nbd.2011.12.053
Mullin, S.
, Stokholm, M. G., Hughes, D., Mehta, A.
, Parbo, P., Hinz, R.
, Pavese, N., Brooks, D. J. & Schapira, A. H. (2021).
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Movement Disorders,
36(3), 774-779.
https://doi.org/10.1002/mds.28375
Aghakhanyan, G., Galgani, A., Vergallo, A., Lombardo, F., Martini, N., Baldacci, F., Tognoni, G., Leo, A., Guidoccio, F., Siciliano, G., Fornai, F.
, Pavese, N., Volterrani, D. & Giorgi, F. S. (2023).
Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study.
Neurobiology of Aging,
122, 12-21.
https://doi.org/10.1016/j.neurobiolaging.2022.11.002
Parbo, P., Ismail, R., Hansen, K. V., Amidi, A., Mårup, F. H., Gottrup, H., Brændgaard, H., Eriksson, B. O. M.
, Eskildsen, S. F., Lund, T. E., Tietze, A., Edison, P.
, Pavese, N., Stokholm, M. G., Borghammer, P., Hinz, R.
, Aanerud, J. & Brooks, D. J. (2017).
Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease.
Brain,
140(7), 2002-2011.
https://doi.org/10.1093/brain/awx120
Horsager, J., Knudsen, K., Andersen, K.
, Skjaerbaek, C., Fedorova, T., Geday, J., Kraft, J., Bech, E.
, Danielsen, E., Moller, M.
, Pavese, N., Brooks, D. & Borghammer, P. (2019).
"Brain-first" vs. "body-first" Parkinson's disease is determined by RBD-status - a multi-modality imaging study.
Movement Disorders,
34(S2), S796-S796.
https://www.mdsabstracts.org/abstract/brain-first-vs-body-first-parkinsons-disease-is-determined-by-rbd-status-a-multi-modality-imaging-study/
Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J.
, Otto, M., Sommerauer, M.
, Danielsen, E. H., Bech, E., Kraft, J.
, Munk, O. L., Hansen, S. D.
, Pavese, N., Göder, R.
, Brooks, D. J. ... Borghammer, P. (2020).
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
Brain,
143(10), 3077-3088.
https://doi.org/10.1093/brain/awaa238
Aanerud, J., Borghammer, P., Chakravarty, M. M., Vang, K., Rodell, A. B., Jónsdottir, K. Y.
, Møller, A., Ashkanian, M., Vafaee, M. S.
, Iversen, P., Johannsen, P.
& Gjedde, A. (2012).
Brain energy metabolism and blood flow differences in healthy aging.
Journal of Cerebral Blood Flow and Metabolism,
32(7), 1177-87.
https://doi.org/10.1038/jcbfm.2012.18
Daglish, M. R. C., Williams, T. M., Wilson, S. J., Taylor, L. G., Eap, C. B., Augsburger, M., Giroud, C.
, Brooks, D. J., Myles, J. S., Grasby, P., Lingford-Hughes, A. R. & Nutt, D. J. (2008).
Brain dopamine response in human opioid addiction.
British Journal of Psychiatry,
193(1), 65-72.
https://doi.org/10.1192/bjp.bp.107.041228
Stær, K., Iranzo, A.
, Stokholm, M., Ostergaard, K., Serradell, M.
, Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C.
, Brooks, D., Borghammer, P., Tolosa, E.
& Pavese, N. (2020).
Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study.
Movement Disorders,
35(S1), S283-S283.
https://onlinelibrary.wiley.com/toc/15318257/2020/35/S1
Ceballos-Baumann, A. O., Sheean, G., Passingham, R. E., Marsden, C. D.
& Brooks, D. J. (1997).
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.
Brain,
120(4), 571-582.
https://doi.org/10.1093/brain/120.4.571
Beaney, R. P.
, Brooks, D. J., Leenders, K. L., Thomas, D. G., Jones, T. & Halnan, K. E. (1985).
Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery.
Journal of Neurology Neurosurgery and Psychiatry,
48(4), 310-319.
https://doi.org/10.1136/jnnp.48.4.310
Galgani, A., Vergallo, A., Campese, N., Lombardo, F.
, Pavese, N., Petrozzi, L., LoGerfo, A., Franzini, M., Cecchetti, D., Puglisi-Allegra, S., Busceti, C. L., Siciliano, G., Tognoni, G., Baldacci, F., Lista, S., Hampel, H., Fornai, F. & Giorgi, F. S. (2022).
Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum.
Journal of Neurochemistry,
163(1), 40-52.
https://doi.org/10.1111/jnc.15686
Vandenberghe, R., Nelissen, N., Salmon, E., Ivanoiu, A., Hasselbalch, S.
, Andersen, A., Korner, A., Minthon, L.
, Brooks, D. J., Van Laere, K. & Dupont, P. (2013).
Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
NeuroImage,
64, 517-25.
https://doi.org/10.1016/j.neuroimage.2012.09.015
Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Björklund, A.
, Brooks, D. J., Marsden, C. D., Oertel, W. H., Quinn, N. P., Rehncrona, S. & Lindvall, O. (2000).
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brain,
123(7), 1380-1390.
Arshad, Q., Bonsu, A., Lobo, R., Fluri, A.-S., Sheriff, R., Bain, P.
, Pavese, N. & Bronstein, A. M. (2017).
Biased numerical cognition impairs economic decision-making in Parkinson's disease.
Annals of clinical and translational neurology,
4(10), 739-748.
https://doi.org/10.1002/acn3.449
Richardson, M. P., Koepp, M. J.
, Brooks, D. J., Fish, D. R. & Duncan, J. S. (1996).
Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An 11C-flumazenil PET study.
Annals of Neurology,
40(2), 188-198.
https://doi.org/10.1002/ana.410400210
Patel, N. K.
, Pavese, N., Javed, S., Hotton, G. R.
, Brooks, D. J. & Gill, S. S. (2013).
Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation.
Neurology,
81(13), 1176-8.
https://doi.org/10.1212/WNL.0b013e3182a55ea5
Cintra, A., Lindberg, J., Chadi, G., Tinner, B.
, Møller, A., Gustafsson, J. Å., DeKloet, E. R., Oitzl, M., Nishikawa, K., Agnati, L. F. & Fuxe, K. (1994).
Basic fibroblast growth factor and steroid receptors in the aging hippocampus of the brown norway rat: Immunocytochemical analysis in combination with stereology.
Neurochem. Int.,
25, 39-45.
Fox, T., Siderowf, A. D., Fernandez, H. H., Tanner, C. M., Postuma, R. B., Simon, D. K., Byrne, M., Lang, A. E.
, Brooks, D., Rascol, O., Tolosa, E., Poewe, W., Stocchi, F., Mollenhauer, B., Giladi, N., Hirschhorn, B., Cedarbaum, J. M., Nomikos, G., Fanning, L. ... Brys, M. (2020).
Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson's Disease (1579).
Neurology,
94(15).
Hammers, A., Asselin, M. C., Turkheimer, F. E., Hinz, R., Osman, S., Hotton, G.
, Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007).
Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test-retest data.
NeuroImage,
38(1), 82-94.
https://doi.org/10.1016/j.neuroimage.2007.06.035
Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C.
, Brooks, D. J., Hyman, B. T., Ikonomovic, M. D., Ishii, K., Jack, C. R., Jagust, W. J., Johnson, K. A., Koeppe, R. A., Lowe, V. J., Masters, C. L., Montine, T. J., Morris, J. C., Nordberg, A., Petersen, R. C., Reiman, E. M. ... Drzezga, A. (2012).
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.
European Journal of Nuclear Medicine and Molecular Imaging,
39(2), 209-19.
https://doi.org/10.1007/s00259-011-2045-0
Angeles, P., Mace, M., Admiraal, M., Burdet, E.
, Pavese, N. & Vaidyanathan, R. (2016).
A Wearable Automated System to Quantify Parkinsonian Symptoms Enabling Closed Loop Deep Brain Stimulation. In L. Alboul, D. Damian & JM. Aitken (Eds.),
Towards Autonomous Robotic Systems - 17th Annual Conference, TAROS 2016, Proceedings (pp. 8-19). SPRINGER INT PUBLISHING AG.
https://doi.org/10.1007/978-3-319-40379-3_2
Jeppesen, J., Otto, M., Frederiksen, Y., Hansen, A. K., Fedorova, T. D., Knudsen, K., Nahimi, A., Brooks, D. J., Borghammer, P. & Sommerauer, M. B. (2018).
Automated chin EMG analysis for quantification of REM sleep without atonia.
Clinical Neurophysiology,
129(Supplement 1), e76. Article F26.
https://doi.org/10.1016/j.clinph.2018.04.189
Angeles, P., Tai, Y.
, Pavese, N., Wilson, S. & Vaidyanathan, R. (2017).
Automated assessment of symptom severity changes during deep brain stimulation (DBS) therapy for Parkinson's disease. In
2017 International Conference on Rehabilitation Robotics, ICORR 2017 (Vol. 2017, pp. 1512-1517). Article 8009462
https://doi.org/10.1109/ICORR.2017.8009462
Perrild, H., Hegedüs, L., Båstrup, P. C., Kastberg, S., Feldt-Rasmussen, U., Beck, K., Madsen, M. H., Kayser, L.
, Møller, A., Hansen, G. N. & Hansen, B. L. (1991).
Autoimmunity in manicdepressive patients given long-term lithium treatment.
Lithium,
2, 155-61.
Salmon, E.
, Brooks, D. J., Leenders, K. L., Turton, D. R., Hume, S. P., Cremer, J. E., Jones, T. & Frackowiak, R. S. J. (1990).
A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
10(3), 307-316.
https://doi.org/10.1038/jcbfm.1990.59
Møller, A., Rømer Thomsen, K., Brooks, D. J., Mouridsen, K., Blicher, J. U., Hansen, K. V. & Lou, H. C. (2019).
Attenuation of dopamine-induced GABA release in problem gamblers.
Brain and Behavior,
9(3), Article e01239.
https://doi.org/10.1002/brb3.1239
Whone, A. L., Bailey, D. L., Remy, P.
, Pavese, N. & Brooks, D. J. (2004).
A technique for standardized central analysis of 6-18F-fluoro-L- DOPA PET data from a multicenter study.
Journal of Nuclear Medicine,
45(7), 1135-1145.
Anderson, A. N.
, Pavese, N., Edison, P., Tai, Y. F., Hammers, A., Gerhard, A.
, Brooks, D. J. & Turkheimer, F. E. (2007).
A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
NeuroImage,
36(1), 28-37.
https://doi.org/10.1016/j.neuroimage.2007.02.017
Knudsen, K., Fedorova, T. D., Horsager, J., Andersen, K. B., Skjærbæk, C., Berg, D., Schaeffer, E.
, Brooks, D. J., Pavese, N., Van Den Berge, N. & Borghammer, P. (2021).
Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes.
Journal of Parkinson's Disease,
11(4), 1677-1687.
https://doi.org/10.3233/JPD-212761
Sawle, G. V., Playford, E. D.
, Brooks, D. J., Quinn, N. & Frackowiak, R. S. J. (1993).
Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naïve parkinsonism: Diagnostic implications of the d2 receptor status.
Brain,
116(4), 853-867.
https://doi.org/10.1093/brain/116.4.853
Kjeldsen, P. L., Parbo, P., Hansen, K. V., Aanerud, J. F. A., Ismail, R., Nissen, P. H., Dalby, R. B., Damholdt, M. F., Borghammer, P. & Brooks, D. J. (2022).
Asymmetrical amyloid deposition in preclinical Alzheimer's disease: A PET study.
Aging Brain,
2, Article 100048.
https://doi.org/10.1016/j.nbas.2022.100048
Samuel, M., Caputo, E.
, Brooks, D. J., Schrag, A., Scaravilli, T., Branston, N. M., Rothwell, J. C., Marsden, C. D., Thomas, D. G. T., Lees, A. J. & Quinn, N. P. (1998).
A study of medial pallidotomy for Parkinson's disease: Clinical outcome, MRI location and complications.
Brain,
121(1), 59-75.
https://doi.org/10.1093/brain/121.1.59
Jansen, W. J., Ossenkoppele, R., Tijms, B. M., Fagan, A. M., Hansson, O., Klunk, W. E., van der Flier, W. M., Villemagne, V. L., Frisoni, G. B., Fleisher, A. S., Lleó, A., Mintun, M. A., Wallin, A., Engelborghs, S., Na, D. L., Chételat, G., Molinuevo, J. L., Landau, S. M., Mattsson, N. ... Amyloid Biomarker Study Group (2018).
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
J A M A Psychiatry,
75(1), 84-95.
https://doi.org/10.1001/jamapsychiatry.2017.3391
Nicolson, R. I., Fawcett, A. J., Berry, E. L., Jenkins, I. H., Dean, P.
& Brooks, D. J. (1999).
Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults.
Lancet,
353(9165), 1662-1667.
https://doi.org/10.1016/S0140-6736(98)09165-X
Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M.
, Otto, M., Svendsen, K. B., Garrido, A., Vilas, D.
, Borghammer, P., Santamaria, J.
, Møller, A., Gaig, C.
, Brooks, D. J., Tolosa, E.
& Pavese, N. (2017).
Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Lancet Neurology,
16(10), 789-796.
https://doi.org/10.1016/S1474-4422(17)30173-4
Brooks, D. J., Frey, K. A., Marek, K. L., Oakes, D., Paty, D., Prentice, R., Shults, C. W. & Stoessl, A. J. (2003).
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental Neurology,
184(SUPPL. 1).
https://doi.org/10.1016/j.expneurol.2003.08.008
Brunt, E. R.
, Brooks, D. J., Korczyn, A. D., Montastruc, J. L. & Stocchi, F. (2002).
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Journal of Neural Transmission,
109(4), 489-502.
https://doi.org/10.1007/s007020200040
Rossi, R., Bærentzen, S. L., Thomsen, M., Real, C. C., Wegener, G., Grassi-Oliveira, R., Gjedde, A. & Landau, A. (2024).
A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.
Acta Neuropsychiatrica,
36(2), 109-117.
https://doi.org/10.1017/neu.2023.14
Fredsø, N., Sabers, A., Toft, N.
, Møller, A. & Berendt, M. (2016).
A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
Veterinary Journal,
208, 44-9.
https://doi.org/10.1016/j.tvjl.2015.10.018
Rønn, L. C. B., Ralets, I., Hartz, B. P., Bech, M., Berezin, A., Berezin, V.
, Møller, A. & Bock, E. (2000).
A simple procedure for quantification of neurite outgrowth based on stereological principles.
Journal of Neuroscience Methods,
100, 25-32.
Williams, S. C. R., Simmons, A., Samuel, M., Brammer, M. J., Bullmore, E. T., Goldstein, L. H., Andrew, C. M., Andrews, C., Glover, A., Allin, M. B.
, Brooks, D. J. & Leigh, P. N. (1997).
A simple FMRI paradigm for mapping the major components of the human motor system.
NeuroImage,
5(4 PART II).
Kew, J., Morris, C., Aihie, A., Fysh, R., Jones, S.
& Brooks, D. (1993).
Arsenic and mercury intoxication due to Indian ethnic remedies.
British Medical Journal,
306(6876), 506-507.
Taylor-Robinson, S. D., Turjanski, N., Bhattacharya, S., Seery, J. P., Sargentoni, J.
, Brooks, D. J., Bryant, D. J. & Cox, I. J. (1999).
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Metabolic Brain Disease,
14(1), 45-55.
https://doi.org/10.1023/A:1020609530444
Chaudhuri, K. R., Rojo, J. M., Schapira, A. H. V.
, Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. G. & Martinez-Martin, P. (2016).
A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need (vol 8, e57221, 2013).
P L o S One,
11(2), Article 0150130.
https://doi.org/10.1371/journal.pone.0150130
Ray Chaudhuri, K., Rojo, J. M., Schapira, A. H. V.
, Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. J. & Martinez-Martin, P. (2013).
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.
PLOS ONE,
8(2), e57221.
https://doi.org/10.1371/journal.pone.0057221
Abrahams, S., Leigh, P. N., Kew, J. J. M., Goldstein, L. H., Lloyd, C. M. L.
& Brooks, D. J. (1995).
A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis.
Journal of the Neurological Sciences,
129(SUPPL.), 44-46.
https://doi.org/10.1016/0022-510X(95)00060-F
Bonuccelli, U., Piccini, P., Del Dotto, P.
, Pavese, N., D'Antonio, P. & Muratorio, A. (1992).
Apomorphine test in de novo Parkinson's disease.
Functional Neurology,
7(4), 295-298.
Brooks, D. J., Abbott, R. J., Lees, A. J., Martignoni, E., Philcox, D. V., Rascol, O., Roos, R. A. C. & Sagar, H. J. (1998).
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.
Clinical Neuropharmacology,
21(2), 101-107.
Spence, S. A.
, Brooks, D. J., Hirsch, S. R., Liddle, P. F., Meehan, J. & Grasby, P. M. (1997).
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control).
Brain,
120(11), 1997-2011.
https://doi.org/10.1093/brain/120.11.1997
Perrild, H.
, Møller, A., Baastrup, P. C., Kastberg, S. & Hegedüs, L. (1987).
Antibodies directed against determinants in the pituitary gland in lithium treated patients.
IRL Press limited, Oxford, 185-7.
Cai, X. L., Pu, C. C., Zhou, S. Z., Wang, Y., Huang, J., Lui, S. S. Y.
, Moller, A., Cheung, E. F. C., Madsen, K. H., Xue, R., Yu, X. & Chan, R. C. K. (2023).
Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal 1H-MRS and fMRI study.
Psychological Medicine,
53(11), 4904-4914.
https://doi.org/10.1017/S0033291722001817
Aamand, R., Dalsgaard, T., Ho, Y. C. L.
, Møller, A., Roepstorff, A. & Lund, T. E. (2013).
A NO way to BOLD? Dietary nitrate alters the hemodynamic response to visual stimulation.
NeuroImage,
83C, 397-407.
https://doi.org/10.1016/j.neuroimage.2013.06.069
Brooks, D. J., Papapetropoulos, S., Vandenhende, F., Tomic, D., He, P., Coppell, A. & O'Neill, G. (2010).
An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.
Clinical Neuropharmacology,
33(2), 55-60.
https://doi.org/10.1097/WNF.0b013e3181d137d2
Woitalla, D., Dunac, A., Safavi, A., Ceravolo, M. G., Gomez Esteban, J. C.
, Pavese, N., Asgharnejad, M., Joeres, L., Schuller, J. C. & Chaudhuri, K. R. (2018).
A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease.
Expert Opinion on Pharmacotherapy,
19(9), 937-945.
https://doi.org/10.1080/14656566.2018.1480721
Lim, N. K.-H., Moestrup, V. T. S., Zhang, X., Wang, W.-A.
, Møller, A. & Huang, F.-D. (2018).
An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice.
Journal of Visualized Experiments,
133(133), Article e56774.
https://doi.org/10.3791/56774
Hu, M. T. M., Chaudhuri, K. R., Jorosz, J., Yaguez, L.
& Brooks, D. J. (2002).
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Movement Disorders,
17(6), 1321-1328.
https://doi.org/10.1002/mds.10261
Senda, M., Yamamoto, Y., Sasaki, M., Yamane, T.
, Brooks, D. J., Farrar, G., McParland, B. J. & Heurling, K. (2015).
An exploratory efficacy study of the amyloid imaging agent [F-18]flutemetamol in Japanese Subjects.
Annals of nuclear medicine,
29(5), 391-399.
https://doi.org/10.1007/s12149-015-0957-7
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A., Jacobs, A. H. & Partners IMBI Project (2019).
A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
Alzheimer's & Dementia,
15(8), 1081-1103.
https://doi.org/10.1016/j.jalz.2019.02.004
Bertelsen, F., Sabers, A.
, Nyengaard, J. R., Alstrup, A. K. O., Møller, A. & Scheel-Krüger, J. (2011).
A new animal model for the fetal valproate syndrome with relevance for epilepsy and autism. Abstract from Tenth annual OAK Meeting, Aarhus C, Denmark.
Yousif, N., Mace, M.
, Pavese, N., Borisyuk, R., Nandi, D. & Bain, P. (2017).
A Network Model of Local Field Potential Activity in Essential Tremor and the Impact of Deep Brain Stimulation.
PLOS Computational Biology,
13(1), e1005326. Article e1005326.
https://doi.org/10.1371/journal.pcbi.1005326
Alstrup, A. K. O., Jakobsen, S., Wegener, G., Hansen, A. K., Doudet, D.
& Landau, A. M. (2010).
Anesthesia in animal imaging: Differing effects of propofol versus isoflurane on dopamine 1 receptor binding in Göttingen minipig brain.
NeuroImage, (1), 181.
Jueptner, M., Frith, C. D.
, Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1997).
Anatomy of motor learning. II. Subcortical structures and learning by trial and error.
Journal of Neurophysiology,
77(3), 1325-1337.
https://doi.org/10.1152/jn.1997.77.3.1325
Jueptner, M., Stephan, K. M., Frith, C. D.
, Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1997).
Anatomy of motor learning. I. Frontal cortex and attention to action.
Journal of Neurophysiology,
77(3), 1313-1324.
https://doi.org/10.1152/jn.1997.77.3.1313
Sperling, R., Salloway, S.
, Brooks, D. J., Tampieri, D., Barakos, J., Fox, N. C., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Lieberburg, I., Arrighi, H. M., Morris, K. A., Lu, Y., Liu, E., Gregg, K. M., Brashear, H. R., Kinney, G. G., Black, R. & Grundman, M. (2012).
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
Lancet Neurology,
11(3), 241-9.
https://doi.org/10.1016/S1474-4422(12)70015-7
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F.
, Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A. ... Drzezga, A. (2020).
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
Lancet Neurology,
19(11), 951-962.
https://doi.org/10.1016/S1474-4422(20)30314-8
Scott LeBlanc, G., Ramlackhansingh, A. F., Edison, P., Hellyer, P. J., Cole, J., Veronese, M., Leech, R., Greenwood, R. J., Turkheimer, F. E., Gentleman, S. M., Heckemann, R. A., Matthews, P. M.
, Brooks, D. J. & Sharp, D. J. (2016).
Amyloid pathology and axonal injury after brain trauma.
Neurology,
86(9), 821-828.
https://doi.org/10.1212/WNL.0000000000002413
Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., Villemagne, V. L., O'Keefe, G., Någren, K., Chaudhury, K. R., Masters, C. L.
& Brooks, D. J. (2008).
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
Journal of Neurology, Neurosurgery & Psychiatry,
79(12), 1331-1338.
https://doi.org/10.1136/jnnp.2007.127878
Archer, H. A., Edison, P.
, Brooks, D. J., Barnes, J., Frost, C., Yeatman, T., Fox, N. C. & Rossor, M. N. (2006).
Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C-PIB positron emission tomography study.
Annals of Neurology,
60(1), 145-147.
https://doi.org/10.1002/ana.20889
Edison, P., Archer, H. A., Hinz, R., Hammers, A.
, Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., Rossor, M.
& Brooks, D. J. (2007).
Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study.
Neurology,
68(7), 501-508.
https://doi.org/10.1212/01.wnl.0000244749.20056.d4
Phan, J.-A., Jakobsen, S., Landau, A. M., Doudet, D. & Gjedde, A. (2012).
Amphetamine-induced inhibition of [C-11]yohimbine binding in rat brain. Poster session presented at The Ninth International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM2012), Baltimore, United States.
Doudet, D.
, Jakobsen, S., Alstrup, A. K. O., Møller, A., Sørensen, J. C. H. & Landau, A. M. (2013).
A model of Parkinson’s disease (PD) in pig and primate by repeated ICV administration of an inhibitor of the ubiquitin proteasome system (UPS). Poster session presented at XX World Congress on Parkinson´s Disease and related disorders, Geneva, Switzerland.
Doudet, D.
, Jakobsen, S., Alstrup, A. K. O., Møller, A., Sørensen, J. C. H. & Landau, A. M. (2013).
A model of Parkinson’s Disease in pig and primate by repeated intraventricular administration of an inhibitor of the ubiquitin proteasome system (UPS). Abstract from XX World Congress on Parkinson´s Disease and related disorders, Geneva, Switzerland.
Bonuccelli, U., Nuti, A., Lucetti, C.
, Pavese, N., Dell'Agnello, G. & Muratorio, A. (1996).
Amitriptyline and dexamethasone combined treatment in drug-induced headache.
Cephalalgia,
16(3), 197-200.
https://doi.org/10.1046/j.1468-2982.1996.1603197.x
Lammertsma, A. A.
, Brooks, D. J., Frackowiak, R. S. J., Heather, J. D. & Jones, T. (1984).
A method to quantitate the fractional extraction of rubidium-82 across the blood-brain barrier using positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
4(4), 523-534.
https://doi.org/10.1038/jcbfm.1984.77
Andersen, K. B., Hansen, A. K., Sommerauer, M.
, Fedorova, T. D., Knudsen, K., Vang, K., Van Den Berge, N., Kinnerup, M., Nahimi, A., Pavese, N., Brooks, D. J. & Borghammer, P. (2020).
Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder: A PET study.
Parkinsonism & Related Disorders,
75, 63-69.
https://doi.org/10.1016/j.parkreldis.2020.05.013
Rømer Thomsen, K., Jønsson, M., Lou, H. O. C.
, Møller, A., Kringelbach, M. L. & Changeux, J.-P. (2012).
Altered self-control and paralimbic activity in pathological gambling. Poster session presented at Psykiatriens 7. Forskningsdag, Aarhus.
Rømer Thomsen, K., Joensson, M., Lou, H. O. C.
, Møller, A., Gross, J.
, Kringelbach, M. L. & Changeux, J.-P. (2013).
Altered paralimbic interaction in behavioral addiction.
PNAS (Proceedings of the National Academy of Sciences of the United States of America),
110(12), 4744-9.
https://doi.org/10.1073/pnas.1302374110
Wang, Y.-M., Zou, L.-Q., Xie, W.-L., Yang, Z.-Y., Zhu, X.-Z., Cheung, E. F. C.
, Sørensen, T. A., Møller, A. & Chan, R. C. K. (2018).
Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity.
Psychiatry Research,
276, 65-72.
https://doi.org/10.1016/j.pscychresns.2018.03.009
Wang, Y., Zou, L., Xie, W., Yang, Z., Zhu, X., Cheung, EFC.
, Sørensen, T. A., Møller, A. & Chan, R. C. K. (2019).
Altered functional connectivity of the default mode network in patients with schizo-obsessive comorbidity: A comparison between schizophrenia and obsessive-compulsive disorder.
Schizophrenia Bulletin,
45(1), 199-210.
https://doi.org/10.1093/schbul/sbx194
Betzer, C., Lassen, L. B., Olsen, A.
, Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W.-P., Chen, T.
, Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B.
, Andersen, J. P. & Jensen, P. H. (2018).
Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation.
EMBO Reports,
19(5), Article e44617.
https://doi.org/10.15252/embr.201744617
Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Dagher, A., Forster, K., Haslinger, B.
, Brooks, D. J., Schwaiger, M. & Conrad, B. (2002).
A H2 15O positron emission tomography study on mental imagery of movement sequences - The effect of modulating sequence length and direction.
NeuroImage,
17(2), 999-1009.
https://doi.org/10.1016/S1053-8119(02)91139-0
Huo, W., Angeles, P., Tai, Y. F.
, Pavese, N., Wilson, S., Hu, M. T. & Vaidyanathan, R. (2020).
A Heterogeneous Sensing Suite for Multisymptom Quantification of Parkinson's Disease.
I E E E Transactions on Neural Systems and Rehabilitation Engineering,
28(6), 1397-1406. Article 9064818.
https://doi.org/10.1109/TNSRE.2020.2978197
Andersen, O. M., Bøgh, N., Landau, A. M., Pløen, G. G., Jensen, A. M. G., Monti, G., Ulhøi, B. P.
, Nyengaard, J. R., Jacobsen, K. R.
, Jørgensen, M. M., Holm, I. E., Kristensen, M. L.
, Alstrup, A. K. O., Hansen, E. S. S., Teunissen, C. E., Breidenbach, L., Droescher, M., Liu, Y., Pedersen, H. S.
... Sørensen, C. B. (2022).
A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency.
Cell Reports Medicine,
3(9), Article 100740.
https://doi.org/10.1016/j.xcrm.2022.100740
Metaxas, A., Thygesen, C., Kempf, S. J., Anzalone, M., Vaitheeswaran, R., Petersen, S.
, Landau, A. M., Audrain, H., Teeling, J. L., Darvesh, S.
, Brooks, D. J., Larsen, M. R. & Finsen, B. (2019).
Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease.
Scientific Reports,
9(1), Article 15758.
https://doi.org/10.1038/s41598-019-52357-5
Rascol, O.
, Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E. & Lang, A. E. (2000).
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
New England Journal of Medicine,
342(20), 1484-1491.
https://doi.org/10.1056/NEJM200005183422004
Nordberg, A., Carter, S. F., Rinne, J., Drzezga, A.
, Brooks, D. J., Vandenberghe, R., Perani, D., Forsberg, A., Långström, B., Scheinin, N., Karrasch, M., Någren, K., Grimmer, T., Miederer, I., Edison, P., Okello, A., Van Laere, K., Nelissen, N., Vandenbulcke, M. ... Herholz, K. (2013).
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.
European Journal of Nuclear Medicine and Molecular Imaging,
40(1), 104-14.
https://doi.org/10.1007/s00259-012-2237-2
Chaudhuri, K. R., Edwards, R., Scott, J.
, Brooks, D. J., Rees, A. & Pusey, C. D. (1993).
Adult moyamoya disease.
British Medical Journal,
307(6908), 852-854.
Ramlackhansingh, A. F., Bose, S. K., Ahmed, I., Turkheimer, F. E.
, Pavese, N. & Brooks, D. J. (2011).
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease.
Neurology,
76(21), 1811-6.
https://doi.org/10.1212/WNL.0b013e31821ccce4
Landau, A. M., Dyve, S.
, Alstrup, A. K. O., Jakobsen, S., Rodell, A.
, Gjedde, A. & Doudet, D. (2010).
Acute vagal nerve stimulation promotes noradrenaline release in minipig brain. Abstract from 16th World Congress of Basic and Clinical Pharmacology, København, Denmark.
Landau, A. M., Dyve, S.
, Jakobsen, S., Alstrup, A. K. O., Gjedde, A. & Doudet, D. (2015).
Acute Vagal Nerve Stimulation Lowers α2 Adrenoceptor Availability: Possible Mechanism of Therapeutic Action.
Brain Stimulation,
8(4), 702-707.
https://doi.org/10.1016/j.brs.2015.02.003
Bertelsen, F.
, Landau, A. M., Vase, K. H.
, Jacobsen, J., Scheel-Krüger, J.
& Møller, A. (2018).
Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [C-11]Ro15-4513 microPET study.
Brain Research,
1680, 110-114.
https://doi.org/10.1016/j.brainres.2017.12.018
Garvey, L. J.
, Pavese, N., Ramlackhansingh, A., Thomson, E., Allsop, J. M., Politis, M., Kulasegaram, R., Main, J.
, Brooks, D. J., Taylor-Robinson, S. D. & Winston, A. (2012).
Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.
PLOS ONE,
7(7), e38980.
https://doi.org/10.1371/journal.pone.0038980
Vibholm, A. K.
, Landau, A., Alstrup, A. K. O., Jacobsen, J., Hansen, K. V., Munk, O. L., Dietz, M., Orlowski, D., Sorensen, J. C. & Brooks, D. J. (2020).
Activation of NMDA receptor ion channels by deep brain stimulation in the pig visualised with [18F]GE-179 PET.
Brain Stimulation,
13(4), 1071-1078.
https://doi.org/10.1016/j.brs.2020.03.019
Vibholm, A. K.
, Dietz, M. J., Beniczky, S., Christensen, J., Højlund, A., Jacobsen, J., Bender, D., Møller, A. & Brooks, D. J. (2021).
Activated N-methyl-D-aspartate receptor ion channels detected in focal epilepsy with [18F]GE-179 positron emission tomography.
Epilepsia,
62(12), 2899-2908.
https://doi.org/10.1111/epi.17074
Rakshi, J. S.
, Pavese, N., Uema, T., Ito, K., Morrish, P. K., Bailey, D. L.
& Brooks, D. J. (2002).
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: An 18F-dopa PET study.
Journal of Neural Transmission,
109(12), 1433-1443.
https://doi.org/10.1007/s00702-002-0753-0
Hu, M. T. M., White, S. J., Herlihy, A. H., Chaudhuri, K. R., Hajnal, J. V.
& Brooks, D. J. (2001).
A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of parkinson's disease.
Neurology,
56(9), 1195-1200.
https://doi.org/10.1212/WNL.56.9.1195
Palmqvist, S., Zetterberg, H., Blennow, K., Vestberg, S., Andreasson, U.
, Brooks, D. J., Owenius, R., Hägerström, D., Wollmer, P., Minthon, L. & Hansson, O. (2014).
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
JAMA Neurology,
71(10), 1282-9.
https://doi.org/10.1001/jamaneurol.2014.1358
Beaney, R. P., Gibbs, J. S. R.
, Brooks, D. J., McKenzie, C. G., Joplin, G. F. & Jones, T. (1987).
Absence of irradiation induced ischaemic temporal lobe damage in patients with pituitary tumours.
Journal of Neuro-Oncology,
5(2), 129-137.
https://doi.org/10.1007/BF02571301
Hammers, A., Koepp, M. J., Hurlemann, R., Thom, M., Richardson, M. P.
, Brooks, D. J. & Duncan, J. S. (2002).
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.
Brain,
125(10), 2257-2271.
https://doi.org/10.1093/brain/awf233
Turner, M. R., Osei-Lah, A. D., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J., Leigh, P. N. & Mills, K. R. (2005).
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
Journal of Neurology, Neurosurgery & Psychiatry,
76(9), 1279-1285.
https://doi.org/10.1136/jnnp.2004.054429
Ismail, R., Parbo, P., Hansen, K. V., Schaldemose, J. L.
, Dalby, R. B., Tietze, A.
, Kjeldsen, P. L., la Cour, S. H.
, Qvist, P., Gottrup, H.
, Eskildsen, S. F. & Brooks, D. J. (2019).
Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold.
Journal of Neuroimaging,
29(4), 499-505.
https://doi.org/10.1111/jon.12629
Kew, J. J. M., Halligan, P. W., Marshall, J. C., Passingham, R. E., Rothwell, J. C., Ridding, M. C., David Marsden, C.
& Brooks, D. J. (1997).
Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees.
Journal of Neurophysiology,
77(5), 2753-2764.
https://doi.org/10.1152/jn.1997.77.5.2753
Schmidt, C., Gleesborg, C., Schmidt, H.
, Kvamme, T. L., Lund, T. E., Voon, V.
& Møller, A. (2021).
A bias towards natural rewards away from gambling cues in gamblers under‐going active treatment.
Brain Research,
1764, Article 147479.
https://doi.org/10.1016/j.brainres.2021.147479
Lingford-Hughes, A., Reid, A. G., Myers, J., Feeney, A., Hammers, A., Taylor, L. G., Rosso, L., Turkheimer, F.
, Brooks, D. J., Grasby, P. & Nutt, D. J. (2012).
A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions.
Journal of psychopharmacology (Oxford, England),
26(2), 273-81.
https://doi.org/10.1177/0269881110379509
Horsager, J., Okkels, N., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Van Den Berge, N., Jacobsen, J., Munk, O. L., Danielsen, E. H., Bender, D., Brooks, D. J. & Borghammer, P. (2022).
[
18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson's disease. Parkinsonism & Related Disorders,
104, 21-25.
https://doi.org/10.1016/j.parkreldis.2022.09.016
Pavese, N., Simpson, B. S., Metta, V., Ramlackhansingh, A., Chaudhuri, K. R.
& Brooks, D. J. (2012).
[¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
NeuroImage,
59(2), 1080-4.
https://doi.org/10.1016/j.neuroimage.2011.09.034
Ceravolo, R., Piccini, P., Bailey, D. L., Jorga, K. M., Bryson, H.
& Brooks, D. J. (2002).
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
Synapse,
43(3), 201-207.
https://doi.org/10.1002/syn.10034
Hyare, H., Ramlackhansingh, A., Gelosa, G., Edison, P., Rudge, P., Brandner, S.
, Brooks, D. J., Collinge, J. & Mead, S. (2012).
11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease.
Journal of Neurology, Neurosurgery & Psychiatry,
83(3), 340-1.
https://doi.org/10.1136/jnnp.2010.233692